Suppr超能文献

反流表型谱

The Spectrum of Reflux Phenotypes.

作者信息

Mahoney Lisa B, Rosen Rachel

机构信息

Dr Mahoney is an instructor in pediatrics and Dr Rosen is an associate professor of pediatrics at Harvard Medical School in Boston, Massachusetts, as well as in the Motility and Functional Gastrointestinal Disorders Center and the Division of Gastroenterology, Hepatology and Nutrition at Boston Children's Hospital in Boston, Massachusetts.

出版信息

Gastroenterol Hepatol (N Y). 2019 Dec;15(12):646-654.

Abstract

The focus on a symptom-based definition for gastroesophageal reflux disease (GERD) in adults and children has contributed to widespread use of acid suppression medications in patients with so-called typical reflux symptoms to treat the possibility of acid-mediated disease. Diagnostic testing with upper endoscopy, esophageal biopsies, ambulatory reflux monitoring, and/or esophageal manometry is often pursued when patients do not respond optimally to these medications. By using information from this diagnostic testing, GERD has shifted from a single diagnosis to a phenotypic spectrum, and each phenotype has unique pathophysiologic mechanisms driving symptom perception. Understanding these mechanisms is important to tailor individualized treatment plans and guide therapeutic interventions. The aim of this article is to discuss the different reflux phenotypes, the utility of esophageal reflux testing, the mechanisms underlying symptoms, and the management strategies for each phenotype.

摘要

对成人和儿童胃食管反流病(GERD)基于症状的定义的关注,促使酸抑制药物在有所谓典型反流症状的患者中广泛使用,以治疗酸介导疾病的可能性。当患者对这些药物反应不佳时,通常会进行上消化道内镜检查、食管活检、动态反流监测和/或食管测压等诊断测试。通过利用这些诊断测试的信息,GERD已从单一诊断转变为表型谱,并且每种表型都有驱动症状感知的独特病理生理机制。了解这些机制对于制定个体化治疗方案和指导治疗干预很重要。本文的目的是讨论不同的反流表型、食管反流测试的效用、症状背后的机制以及每种表型的管理策略。

相似文献

1
The Spectrum of Reflux Phenotypes.
Gastroenterol Hepatol (N Y). 2019 Dec;15(12):646-654.
2
The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
J Pediatr. 2017 Oct;189:86-91. doi: 10.1016/j.jpeds.2017.06.019. Epub 2017 Jul 12.
3
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
World J Gastroenterol. 2012 Aug 28;18(32):4363-70. doi: 10.3748/wjg.v18.i32.4363.
4
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2.
5
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4.
6
Untangling Nonerosive Reflux Disease From Functional Heartburn.
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1314-1326. doi: 10.1016/j.cgh.2020.03.057. Epub 2020 Apr 1.
7
AGA Clinical Practice Update on Functional Heartburn: Expert Review.
Gastroenterology. 2020 Jun;158(8):2286-2293. doi: 10.1053/j.gastro.2020.01.034. Epub 2020 Feb 1.
9
Current advances in the diagnosis and management of gastroesophageal reflux disease.
Tzu Chi Med J. 2022 May 16;34(4):402-408. doi: 10.4103/tcmj.tcmj_323_21. eCollection 2022 Oct-Dec.

本文引用的文献

1
Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet.
Clin Gastroenterol Hepatol. 2020 Apr;18(4):767-776. doi: 10.1016/j.cgh.2019.07.015. Epub 2019 Jul 15.
3
Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children: A Systematic Review.
J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):811-817. doi: 10.1097/MPG.0000000000002280.
4
Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.
Am J Gastroenterol. 2019 Mar;114(3):414-421. doi: 10.1038/s41395-018-0287-1.
5
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10.
6
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6.
7
Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Clin Gastroenterol Hepatol. 2019 May;17(6):1073-1080.e1. doi: 10.1016/j.cgh.2018.06.018. Epub 2018 Jun 18.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验